Similarly Kim et al., showed that a kinase inhibitor that targets both IGF-1R and InsR, OSI-906 (linsitinib), caused inhibition of cell proliferation notably in NSCLC with wt EGFR and wt K-Ras [22]. Here, INSR is linked to non-small cell lung carcinoma.